Clinical Trials Directory

Trials / Completed

CompletedNCT03741309

Comparison of Clinical Efficacy of a Dentifrice Containing 5% Fluoro Calcium Phosphosilicate to a Dentifrice Containing Calcium Sodium Phosphosilicate on Dentinal Hypersensitivity

Comparison of Clinical Efficacy of a Dentifrice Containing 5% Fluoro Calcium Phosphosilicate to a Dentifrice Containing Calcium Sodium Phosphosilicate and to a Placebo on Dentinal Hypersensitivity : a Randomized Clinical Trial

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
131 (actual)
Sponsor
Government Dental College and Research Institute, Bangalore · Academic / Other
Sex
All
Age
25 Years – 50 Years
Healthy volunteers
Accepted

Summary

Aim of this study was to assess and compare the efficacy of a dentifrice containing 5% fluoro calcium phosphosilicate and dentifrice containing calcium sodium phosphosilicate on Dentinal Hypersensitivity (DH) compared to a placebo over a period of 6 weeks.

Detailed description

A total of 131 subjects were divided into 3 groups randomly. Group I was given the dentifrice containing 5% fluoro calcium phosphosilicate ,Group II was given the dentifrice containing calcium sodium phosphosilicate and group III was given placebo. Sensitivity scores (VAS score) were recorded at baseline, 2 weeks, 6 weeks.

Conditions

Interventions

TypeNameDescription
OTHER5% fluorocalcium phosphosilicate dentifricedentifrice containing 5% fluorocalcium phosphosilicate and VAS score assessed at Baseline, 2 weeks, 6 weeks.
OTHERCalcium sodium phosphosilicateCalcium sodium phosphosilicatand VAS score assessed at Baseline, 2weeks, 6 weeks.
OTHERPlacebo dentrificeplacebo dentifrice and VAS score assessed at Baseline, 2weeks, 6 weeks.

Timeline

Start date
2017-12-20
Primary completion
2018-02-16
Completion
2018-02-24
First posted
2018-11-14
Last updated
2018-11-14

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT03741309. Inclusion in this directory is not an endorsement.